New York, New York (PRWEB) May 24, 2015
The federal court overseeing hundreds of testosterone treatment lawsuits (http://www.testosteronelawsuithub.com/) has scheduled its next monthly Case Management Conference to discuss the progress of the multidistrict litigation. According to court documents filed in the U.S. District Court, Northern District of Illinois, the Conference will be convened on June 2, 2015, at 1:30 p.m. (In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)
“Our Firm is representing clients who have filed testosterone lawsuits in this proceeding. We are looking forward to the June 2nd Conference, as it will likely include discussions regarding discovery, bellwether trial selection and other matters that could impact our clients’ cases,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free case reviews to men who may have been harmed by low testosterone therapy medications.
According to court documents, more than 1,400 testosterone lawsuits have been filed in the federal litigation underway in Illinois. The litigation was established in June 2014, several months after the U.S. Food & Drug Administration’s (FDA) announced that it was conducting a review of the cardiovascular risks potentially associated with the use of testosterone replacement therapy.* The results of that review were announced by the FDA on March 3, 2015, at which time the agency ordered the manufacturers of prescription testosterone treatments to modify their labels with information regarding a potential association with an increased risk of heart attack and stroke.
Court documents indicate that all of the claims pending in the federal litigation allege the manufacturers of testosterone replacement medications concealed their alleged association with heart attacks, strokes, blood clots and other life-threatening complications. Plaintiffs further assert that sales of low testosterone therapy products were driven by misleading marketing claims that positioned the drugs as safe and effective treatments for low libido, muscle loss, fatigue and other symptoms commonly associated with male aging, even though they have never been approved by the FDA for this purpose.
Men who allegedly experienced dangerous cardiovascular complications due to their use of low testosterone treatments may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP’s website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.
*http://www.fda.gov/Drugs/DrugSafety/ucm383904.htm, FDA, January 31, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs’ firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com